 HANOVER, MD, Sept. 07, 2022 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA, a clinical stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have an unmet medical need condition today announced that Dr. Dr. David Young, Chief Executive Officer, will present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 14, 2022. 